Opinion|Videos|June 19, 2024
Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates
The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- Could you discuss disease modifying and other therapies for Alzheimer disease that are currently in development?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
RSV Vaccine Shows 100% Effectiveness in COPD: Jorgen Vestbo, MD
3
5 Things to Know About the 2026 ESC Heart Failure Guidelines
4
FDA Shortens Tarlatamab Monitoring, Widens Access to SCLC Care
5